Bausch + Lomb (NYSE:BLCO) received US FDA clearance for its Bi-Blade+ dual-port vitrectomy cutter and Adaptive Fluidics update, expanding its retina surgery toolkit. The company launched the enVista ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...
FDA clearance for its Bi-Blade+ advanced dual-port vitrectomy cutter and Adaptive Fluidics update for the Stellaris Elite ...
Hello, Dear Readers! Just a quick update to let you know that my eye surgery (a vitrectomy for vitreomacular traction) took ...
My niece was diagnosed with birdshot chorioretinopathy.
View Bausch + Lomb Corporation BLCO stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results